China’s NHSA Releases 2024 Healthcare Security Bulletin Highlighting Insurance Coverage and Reimbursement
China’s National Healthcare Security Administration (NHSA) has released its 2024 “Healthcare Security Development Statistical Bulletin.”...
NHSA (prev. SMIA)
China’s NHSA Issues Guidelines for Neurological Medical Services Pricing
China’s National Healthcare Security Administration (NHSA) has released the “Guidelines for the Pricing Project Initiation...
In-Depth Analysis of the National Healthcare Security Policy: A Guide to Key Reforms and Implications
The National Healthcare Security Administration (NHSA) has unveiled its 2025 priority action list, focusing on...
China’s Drug Procurement Under Scrutiny: Addressing Quality Concerns and Policy Reforms
An In – Depth Exploration of the Recent Survey on Bulk Drug Procurement in China...
In-Depth Analysis of NHSA’s DRG/DIP Payment Reforms: A Path to Streamlined Healthcare Management
Comprehensive Overhaul of Payment SystemsThe National Healthcare Security Administration (NHSA) has unveiled a series of...
NHSA Regulates DRG/DIP Payment Methods Under ‘1+3+N’ System
The National Healthcare Security Administration (NHSA) has released a set of regulations aimed at improving...
China’s NHSA and MoF Push for DRG/DIP Payment Reforms by 2025
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly released...
NHSA Targets Low-Volume Drugs in National Reimbursement List
The National Healthcare Security Administration (NHSA) in China has released a list of 131 drugs...
NHSA Outlines 2025 Work Plan and 2024 Medical Insurance Status
The National Healthcare Security Administration (NHSA) last week held a press conference, addressing questions regarding...
NHSA Seeks Expert Opinions on VBP Drug Quality and Efficacy
The National Healthcare Security Administration (NHSA) has released a letter titled “Letter on Requesting Assistance...
NHSA Pushes for Real-Time Settlement Reform in Basic Medical Insurance
The National Healthcare Security Administration (NHSA) has released a notification to promote the real-time settlement...
Suzhou Ribo and Boehringer Ingelheim Reach Pre-Clinical Milestone in NASH/MASH Partnership
China-based Suzhou Ribo Life Science Co., Ltd has announced the achievement of a first pre-clinical...
NHSA Launches Nationwide Self-Inspection Campaign on Medical Insurance Fund Usage
China’s National Healthcare Security Administration (NHSA) released a notification last weekend, mandating designated medical institutions...
China’s NHSA Implements New Regulations for Medical Insurance Payment Qualifications
China’s National Healthcare Security Administration (NHSA) has released the “Regulations on the Management of Medical...
NHSA Strengthens Medical Security Rights for Workers in China
China’s National Healthcare Security Administration (NHSA) has released the “Notice on Further Strengthening the Protection...
China’s Healthcare Bureaus Remove Drug Quantity Limits to Enhance NRDL Access
The healthcare security administration bureaus in Shanghai, Beijing, and other regions have recently removed limits...
Beijing Conference Outlines 2025 Healthcare Security Goals and 2024 Progress
A national conference on healthcare security was recently held in Beijing, reviewing the achievements of...
China’s NHSA and NHC Issue Guidelines to Enhance Volume-based Procurement Mechanism
The National Healthcare Security Administration (NHSA) and National Health Commission (NHC) of China have released...
China’s NHC Launches Pilot Plan to Expand Wholly Foreign-Owned Hospital Sector
The National Health Commission (NHC) has released the “Pilot Work Plan for Expanding the Wholly...
National Reimbursement Drug List 2024 Expands Coverage with 91 New Drugs
The National Medical Products Administration has released the finalized National Reimbursement Drug List (NRDL) for...